United States, March 20 -- Generative AI is at the forefront of global innovation in both health care and life sciences. To better understand how technology is being used, data and AI leader SAS and Coleman Parkes Research conducted a global, cross-industry survey of 237 life sciences and pharma leaders and 240 health care leaders who are decision makers on their organization's GenAI, data and analytics strategy.The study offers a deep dive into how these sectors are implementing GenAI, what their biggest challenges are and how health care and life sciences compares to industries like insurance, the public sector, banking, manufacturing and more.Health care leans into GenAI innovationThe GenAI research for the health care sector revealed th...